Policymakers and advocates hoped landmark lawsuits against Sutter Health could be a blueprint to mitigate high prices driven by hospital consolidation.
More than a dozen years ago, California consumers sued one of the state’s largest hospital systems, claiming it had blocked competition and raised prices on patients.
Sutter Health, the two lawsuits said, had acquired nearby hospitals and used its leverage to push health insurers into unfair contracts. The contract terms stripped insurers of the option to reject high-priced Sutter hospitals from their networks or to steer patients toward less-costly alternatives, the cases claimed. Sutter denied the allegations.
The vast majority of U.S. hospitals face very little competition, and numerous studies show hospital consolidation drives up prices. Patient advocates and policymakers — including the California attorney general, who joined one of the suits against Sutter — looked to these cases as a potential blueprint to mitigate the pricing power of hospital behemoths nationwide.
“The protection of competition is so important right now,” said Katie Gudiksen, a health care competition expert at the University of California College of the Law, San Francisco.
The Sutter litigation finally ended last year, so I wanted to know: Did it bring down costs, as so many hoped?
The answer, as it so often is in health care, is complicated. But according to nearly a dozen lawyers, economists, employers and researchers I spoke with, the Sutter Health cases definitely made a difference.
Here are a few takeaways:
- Some California consumers got money back in their pockets. Sutter Health agreed to pay about $800 million to settle the two cases, without admitting any wrongdoing. The money goes to individuals and employers who paid premiums for health insurance that included Sutter. For example, the health plan for government employees and retirees in San Francisco received at least $14 million, which it used to lower premiums. The eye-popping settlement amounts put other hospital systems on notice that they could be vulnerable to similar litigation, experts said.
- Less clear is whether California markets are more competitive. Under one settlement, Sutter agreed to drop business practices the cases claimed were anticompetitive. Little is publicly known about whether that has lowered costs for insurers, employers and patients, researchers said. Contracts between hospitals and insurers remain confidential, and consolidation in California continues. “If you were to ask me how much more competitive the California hospital market is, I would have a hard time pointing to any real improvements,” said Barak Richman, a George Washington University law professor who studies health care competition.
- At least four states enacted laws informed by the Sutter cases, banning some or all business practices detailed in complaints, according to Gudiksen. Researchers were also able to use previously confidential details from Sutter’s contracts to increase their understanding of the impact those practices had on Sutter’s prices. “The legal case actually opened up a little treasure chest for researchers like me,” said Glenn Melnick, a health economist at the University of Southern California, who used case records to study Sutter prices.
- The Sutter litigation inspired additional lawsuits taking on big hospital systems. There are seven active lawsuits going after these business practices, including at least four that directly cited Sutter in their court filings, according to an analysis by Georgetown University researcher Isaac Kabrick. Legal experts cautioned, however, that because the cases settled without reaching a verdict, their legal weight is limited. Sutter’s cases “involved unproven, disputed allegations,” the system’s spokesperson said. “Sutter has put these disputes behind us, and the settlements have not changed our priorities for serving our patients or slowed our progress.”
We hope you’ll listen to the episode or read the transcript. You’ll learn more about the impact of these cases in California and nationwide. You’ll also hear legal and economic experts struggle to describe the Sutter lawsuits’ legacy in a single word.
Episode Transcript and Resources
Episode Transcript
Dan Gorenstein (DG): America’s anxiety about health care affordability is reaching a new intensity.
News clip: Americans are bracing for healthcare to get even more expensive next year.
News clip: Millions of families are losing their health insurance.
News clip: Voters definitely had healthcare costs on their mind.
DG: A lot of talk about blunting these costs is focused on hospitals and the power many of them have to keep prices high without competition.
Brian Miller: Hospital consolidation is bad… sounds sort of like Sesame Street, but it is.
DG: Recent lawsuits and reports claim hospitals have bullied their way into charging more, using anticompetitive business practices.
By one estimate, banning them could lower U.S. health spending by $25 billion in the next ten years.
This isn’t a new idea. More than a decade ago, consumers went to court with a big, splashy challenge to Sutter Health.
News clip: Northern California’s largest hospital system slapped with a lawsuit.
News clip: It’s time to hold health care corporations accountable.
DG: Today, the legacy of these cases against Sutter Health in the fight to drive down health care spending.
From the studio at the Leonard Davis Institute at the University of Pennsylvania, I’m Dan Gorenstein. This is Tradeoffs.
*****
DG: Tradeoffs reporter Melanie Evans is here to help us dive into the legacy of these lawsuits.
Hello Melanie.
Melanie Evans (ME): Hi Dan.
DG: Tradeoffs covered this litigation against Sutter Health in one of its first episodes. It’s been a long while. The podcast just turned seven.
ME: Happy birthday to us! Is there cake?
DG: Of course you’d ask if there’s cake. No, I’m sorry, just the gift of reporting on health care costs.
ME: Sadly, this is the gift that has been giving throughout my entire career.
DG: True. Me too.
A lot has happened since that early episode. Can we start with a refresher on these lawsuits, please.
ME: Gladly.
The backdrop for these cases is that after decades of hospitals snapping each other up, the vast majority of hospitals in the United States are in markets with very little competition.
And that, Dan, has driven up prices. A study out of Yale University found that hospitals with a monopoly set prices that were 12% higher than hospitals in markets with more competition.
Simply, consolidation makes it harder to cut spending, which is what most lawmakers and regulators want.
DG: And its frustrating, right, because if you could somehow unwind these hospital mergers it would be easier to achieve that goal.
But, hard to unscramble the egg, as the old cliche goes.
ME: Another cliche, put the toothpaste back in the bottle.
Anyway. This all brings us to Sutter. The giant in northern California.
A health system with 27 hospitals, more than 300 clinics and other centers. In some parts of the state, it is the only game in town.
DG: Classic consolidation story, Melanie.
ME: Because of that consolidation, antitrust enforcers are now paying close attention to how these giants behave.
I was talking to George Washington University Professor Barak Richman and he said something I found striking.
Barak Richman (BR): You’re allowed to be a monopoly, but you can’t behave badly. You can’t leverage or exploit or use your monopoly power in ways that prevents competition or entrenches your own monopoly power or stifles other kinds of competitive threats.
ME: In other words, it’s not necessarily illegal to be big. But, being a big bully to squash competition is illegal.
DG: And Sutter was being a bully?
ME: That’s what the plaintiffs alleged, that Sutter was so big, so powerful it could stick health insurers with contracts that shut out competition.
The cases claimed Sutter used anticompetitive business practices, which raised consumers’ prices.
Here’s one example: Sutter blocked insurers from grouping hospitals into high- and low-priced tiers, which is a nudge the insurers use to promote higher quality, lower cost hospitals.
DG: Yeah. I’ve had insurance plans like that. I pay less if I use the hospital my insurer thinks is a better value.
ME: Exactly. There are lots of policymakers who think it’s unfair to take that kind of nudge off the table and hospitals should be barred from doing it.
Another tactic the lawsuits cited was called “all or nothing” contracting.
Here’s Barak again:
BR: They said to employers, they said to insurers, if you want to have access to any of our hospitals where we are the only hospital in town, you also have to pay us for the hospitals where there’s competition.
ME: Think about this for a second, Dan.
You are an insurance company. You are trying to pick which hospitals to include in your network as a way to keep costs down for your customers.
And you need some Sutter hospitals because they are the ONLY option in some markets, but others are super expensive and there are competitors.
But Sutter says ‘all of us, or none of us.’
DG: That’s some bold market power, Melanie. This is why the lawsuits said Sutter was helping drive up costs in the Golden State.
ME: That’s right. And there is some evidence to back that up.
One study found that after Sutter started using all-or-nothing contracts, it’s prices jumped about 30% compared to other hospitals.
Another paper showed the average price for hospital procedures was 70% higher in northern California, where Sutter dominates the market, than in southern California.
DG: And that’s what really excited policymakers and researchers about these lawsuits, right?
That by going after these wonky contract terms, they could lower the cost of getting care at these big, consolidated health systems.
Not unscramble the eggs, but at least make the omelette a little cheaper.
ME: Exactly.
DG: So when our story came out in 2019, one lawsuit against Sutter brought by the state of California had just settled.
And another case settled in 2025. What’s the upshot of these?
ME: Sutter made some big concessions.
They agreed to pay more than three-quarters of a billion dollars to consumers across both settlements. Sutter also said it would stop the business practices described in the lawsuits.
Sutter, however, didn’t admit they had done anything wrong.
Dan, I reached out to Sutter for this story. They declined an interview, but in an email, a spokesperson said the allegations were unproved, disputed and Sutter has put it all behind them.
DG: Okay. Got it. No wrongdoing, but a settlement.
How was that money divvied up, Melanie?
ME: Some of it goes to individual patients.
Employers and unions that manage worker health benefits, they also got cash.
For example, the plan that represents government employees and retirees in San Francisco got a payout of at least $14 million, which it used to lower the cost of future premiums.
DG: What about Sutter’s behavior, what the lawsuits called anticompetitive behavior?
The hospital agreed to stop the practices named in the lawsuits. Has that led to lower costs like people hoped?
ME: That’s a tougher question to answer, Dan.
We do know it created new legal restrictions for Sutter’s contracts.
Elizabeth Mitchell: There are new rules of the road. Basically you can’t do that anticompetitive contracting anymore.
ME: So that’s Elizabeth Mitchell. She runs the Purchaser Business Group on Health, or PBGH. And she was speaking at a conference I was at in New York this fall.
PBGH represents employers and purchasers that manage the health plans that cover about 25 million people nationwide, including in some of Sutter’s markets.
Elizabeth told the crowd she believes the new rules for Sutter leveled the playing field for PBGH members, many of whom were in the dark because insurers agreements with hospitals are confidential.
Elizabeth Mitchell: One of the things that was interesting to me about the Sutter case is, like, that it wasn’t that employers just knew what was going on. They were not allowed to see the contracts. When you think about that from a buyer perspective, it’s absurd.
ME: That said, when I followed up with Elizabeth later, she couldn’t point to any data on how her members now benefit from this new playing field.
And Dan, I heard the same from researchers and attorneys, like Barak Richman at GW.
BR: If you were to ask me how much more competitive the California hospital market is, I would have a hard time pointing to any real improvements.
DG: That sounds pretty bleak, Melanie.
Those big hopes that these lawsuits would be game-changing landmark cases, is that a bust? Because it kinda sounds that way.
ME: That might be a little strong. There could be employers or health plans in California who have seen real benefits. But, as you know, contracts between systems and insurers are confidential, so it would be hard for us to know one way or the other.
Most experts I spoke with also never expected these lawsuits would have a huge impact on local markets.
DG: That’s surprising. Why not?
ME: Well, the cases targeted a single health system. The settlements only prohibited a few specific business practices. And most importantly, Sutter still holds significant power in the market.
DG: The egg, as it were, still scrambled.
ME: Yes, but there’s more to the story. I did find a more substantial legacy outside California. These cases, as it turns out, had a reach that extended to statehouses and courthouses across the country.
DG: When we come back, the legacy of the Sutter Health cases nationwide.
BREAK
DG: Welcome back. We’re examining the impact of two landmark lawsuits on hospitals’ pricing power.
The lawsuits claimed hospital giant Sutter Health in California pushed health insurers into contracts that stifled competition and raised prices. Sutter denied the allegations and settled.
We wanted to understand the legacy of these cases and put Tradeoffs reporter Melanie Eavns on the task.
ME: Fortunately, Dan, I found myself at another conference.
DG: This is becoming a habit.
ME: I will not apologize! This conference was perfect for this story, chock full of economists and attorneys and policymakers, all talking about competition.
DG: Your people!
ME: My people! I cornered one expert after another and I asked them the same question.
In one word how would you describe the legacy of the Sutter Health litigation?
DG: What kind of responses did you hear?
ME: Well, not always one word. Sometimes three or four.
DG: Hardly a surprise given the room.
ME: They have lots to say, Dan. But a few of those answers captured what I learned in interviews with 10 experts for this story.
Let’s start with Anna Sinaiko, an economics and health policy researcher at Harvard University, who I caught during lunch on the outdoor patio.
ME: How would you describe the legacy of Sutter Health?
Anna Sinaiko (AS): Um, informative.
ME: All right. Now you get more than one word. Why would you say informative?
AS: It really seems like it, from my perspective, opened up a lot of understanding and insight into how contracts work.
ME: What Anna is saying here is a big deal, Dan. As we’ve talked about, contracts between hospitals and payers are confidential.
That makes it all but impossible for consumers, regulators and researchers to understand how companies truly behave.
DG: To see what a hospital bully can look like in real time.
ME: Correct. Sutter’s contracts ended up in public court documents creating an opportunity to better understand how these markets work and for whom.
Glenn Melnick (GM): The legal case actually opened up a little treasure chest for researchers like me.
ME: That’s Glenn Melnick, a health economist at the University of Southern California.
Glenn studies hospital market competition. He knew from his work and other studies that consolidation raises hospital prices.
But he didn’t really know how hospitals got those higher rates.
GM: We couldn’t find out what was going on behind the scenes at the negotiating table.
ME: Then he and a colleague got their hands on Sutter’s court filings.
One of the things they did was dig into those all-or-nothing terms.
DG: You mean where Sutter told insurers if they wanted to contract with one hospital, they had to take them all?
ME: Right. Glenn wanted to know: Could he find a connection between those terms and Sutter’s prices.
And boy did he.
GM: The prices started to deviate from all other hospitals and that difference kept growing and growing over time.
ME: Before the break I had mentioned a study that found Sutter’s prices were about 30% higher than similar hospitals after it adopted all-or-nothing terms.
Glenn was the lead author on that, and he was only able to do it because of the info made public by the lawsuits.
DG: Did you see any other ripple effects as Sutter’s contracts got this sunlight?
ME: Yeah. It opened the door for states to legislate against these practices.
I talked with Katie Gudiksen about this. Katie is at University of California College of The Law, San Faransico, right in Sutter’s backyard.
Katie Gudiksen (KG): My office is like one block away from the courthouse where the AG’s case was.
ME: Kaite would pop over to the courthouse for hearings as the case moved towards trial. Then she’d come back to her office and blog about it.
DG: Blogging. That’s a throwback. She’s been covering this case for a while.
ME: She has. Indeed.
Katie read through court records for descriptions of Sutter’s business practices, which helped her draft model legislation for states to ban some of these practices, including all-or-nothing contracts.
KG: At least in some of those states, that model legislation really played a role in the legislative debates and sort of getting it across the finish line.
DG: How many states are we talking about?
ME: Katie says she heard from people in Nevada and Connecticut as those states passed bans.
The lawsuits, she says — if not the model legislation she helped draft — also inspired action in Texas and Indiana.
DG: Ok, at least four states have new laws on the books thanks in part to these Sutter cases. Pretty impressive.
What else did you hear about from the experts you spoke with?
ME: Well, in addition to legislation, the cases against Sutter Health also informed additional litigation.
That’s the legacy that Cory Capps pointed to when I caught him mid-bite during lunch at the conference.
ME: It was like a skill I had as a waiter. I would always walk up when somebody had taken a bite.
Cory is a former Justice Department economist and now works for Bates White Economic Consulting. He also advised the state of California on the Sutter matter.
His answer to my one-word challenge:
Cory Capps (CC): Is DOJ one word?
ME: I asked him why the Department of Justice popped into his head when I asked for Sutter’s legacy.
CC: They filed cases against OhioHealth in Ohio, obviously, NewYork-Presbyterian, that echoed the central complaints of Sutter.
ME: The DOJ brought both cases this year and just like Sutter, they alleged that these two hospital giants used their market power to force insurers to accept unfair contract terms.
Within months the department reached a settlement with OhioHealth, which agreed to stop some practices that Sutter Health dropped. And the Presbyterian case is now headed to trial.
DG: Is it clear Melanie how much the Sutter cases inspired these Ohio and New York suits?
ME: So DOJ lawyers cited Sutter in their OhioHealth arguments, and legal experts told me the Sutter cases inspired the lawsuits that followed.
We know there are seven active lawsuits going after these business practices, according to Georgetown University.
DG: Okay, so just to review here, we’ve got a handful of lawsuits, so far, that owe at least something to the Sutter cases and at least four states that have passed legislation informed by the lawsuits. Sounds like a pretty robust legacy.
ME: Yes, but there is one caveat that almost everyone I talked to brought up.
I think Martin Gaynor, an economist and former Federal Trade Commission and DOJ official summed it up well when I asked him my question at the D.C. conference.
ME: In one word how would you describe the legacy of the Sutter Health litigation?
MG: Three words: important in principle.
ME: He’s a professor emeritus, so he gets three words. He’s earned it.
DG: Really grading on a curve here, Evans.
ME: Thank you. Martin’s point is that because Sutter settled, no judge or jury ever said what Sutter did was definitely illegal.
Other lawsuits can point to the arguments and the settlement, that’s important, and it put hospitals on notice that they could get sued too.
But absent a verdict, the legal weight of these cases is limited.
DG: Fair enough. We can always count on you, Melanie, to bring the nuance.
So after talking to all these experts, I got to ask, how would you describe the legacy of Sutter in one word?
ME: No. Hoisted on my own petard! Ah, Okay… concrete.
DG: Concrete. You are killing me Melanie.
ME: Here’s the thing. Stay with me. These cases produced specific, tangible examples of the opaque practices that go into setting hospital prices.
Those are the prices that show up in our premiums.
I heard again and again that this really matters for policymakers and employers who are urgently seeking ways to control health spending. Many see these practices as unfair and costly. They are now a target.
It is not hypothetical. It is tangible, real-world, so…
DG: Concrete.
I see, basically, real examples of these practices have raised their profile and made it easier to go after them.
ME: That’s right, Dan. Hospital and physician prices would drop by as much as 18% if these practices were banned nationwide, according to advisors to the White House.
Democrats entering Congress have an ambitious health care agenda, so we’ll see if this kind of proposal goes anywhere.
If it does, Sutter deserves some of the credit.
DG: Melanie Evans, thanks for your reporting on this.
ME: You’re welcome.
Additional Reporting & Resources
Additional Reporting and Resources on health care consolidation, prices and litigation against Sutter Health:
- Banning Anticompetitive Contracts to Lower Health Care Costs (Committee for a Responsible Federal Budget, 10/22/2026)
- Effects of Banning Anti-Competitive Hospital Contracts (White House Council of Economic Advisors, 6/18/2026)
- Anticompetitive Contracts Between Insurers and Providers in Health Care (Anna Sinaiko, Journal of Economic Perspectives, 2026)
- Challenges To Anti-Competitive Hospital Contracting Practices: The New York And Presbyterian Hospital (Isaac Kabrick and Katie Keith, Health Affairs, 3/3/2026)
- Sutter Health will pay nearly $230 million to settle class-action antitrust case (Tara Bannow, STAT, 4/25/2025)
- Are “all or nothing” contracts by hospital systems anti-competitive?—evidence from a recent antitrust law (Glenn Melnick, Katya Fonkych, Journal of Hospital Management and Health Policy, 8/23/2024)
- Weighing Policy Trade-offs: Overview of NASHP’s Model Prohibiting Anticompetitive Contracting(Johanna Butler, Katherine L. Gudiksen, Erin Fuse Brown; National Academy for State Health Policy; 9/29/22)
- Sutter Health to Pay $575 Million to Settle Antitrust Lawsuit (Katie Thomas, The New York Times, 12/20/2019)
- The Source on Healthcare Price and Competition: UFCW & Employers Benefit Trust v. Sutter Health (University of California College of the Law, San Francisco)
- The Source on Healthcare Price and Competition: Sidibe v. Sutter Health (University of California College of the Law, San Francisco)
- Health Care Litigation Tracker (Georgetown University O’Neill Institute for National and Global Health Law)
Episode Credits
Guests:
- Cory Capps, partner, Bates White Economic Consulting
- Martin Gaynor, Emeritus University Professor of Economics and Public Policy at Carnegie Mellon University; former Director of the Bureau of Economics, Federal Trade Commission
- Katherine Gudiksen, Executive Editor, The Source on Healthcare Price and Competition, University of California College of the Law, San Francisco
- Glenn Melnick, Professor; Blue Cross of California Chair in Health Care Finance, University of Southern California Sol Price School of Public Policy
- Elizabeth Mitchell, President and Chief Executive Officer, Purchaser Business Group on Health
- Barak Richman, Professor of Business Law; co-director of the Health Law and Policy Program, George Washington University Law School
- Anna Sinaiko, Associate Professor of Health Economics and Policy, Harvard T.H. Chan School of Public Health
This episode was reported by Melanie Evans, edited by Ryan Levi and Dan Gorenstein and mixed by Andrew Parrella and Cedric Wilson.
The Tradeoffs theme song was composed by Ty Citerman. Additional music this episode from Blue Dot Sessions and Epidemic Sound.
Special thanks to Isaac Kabrick, Katie Keith, Julie Selesnick and Christopher Whaley.
Tradeoffs reporting for this story was supported, in part, by the California Health Care Foundation.
